A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Endocarditis de tipo infecciosa
A usted lo hospitalizarán, de manera que pueda recibir antibióticos por vía intravenosa. Se requiere tratamiento de antibióticos prolongado y en altas dosis para erradicar las bacterias. Dicho tratamiento generalmente se administra durante 4 a 6 semanas, dependiendo del tipo específico de la bacteria. Los exámenes de sangre le ayudarán al médico a escoger el mejor antibiótico.
Se puede necesitar cirugía para reemplazar las válvulas cardíacas dañadas.
Por lo general, el tratamiento temprano de una endocarditis bacteriana tiene un pronóstico alentador. Si el diagnóstico y el tratamiento se retrasan puede presentarse daño valvular.
Consulte con el médico si nota los siguientes síntomas durante o después del tratamiento:
Fowler VG Jr, Scheld WM, Bayer AS. Endocarditis and Intravascular Infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2009; chapt 77.
Karchmer AW. Infective Endocarditis. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. St. Louis, Mo: WB Saunders; 2007:chap 63.
Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Oct 9;116(15):1736-54.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885